1. Pink Sheet

EMA ‘Trying Its Best’ To Offer More Early Scientific Support For Sponsors

 
• By Eliza Slawther

The head of the European Medicines Agency’s scientific advisory office is hopeful that the organization’s PRIME initiative will be enshrined in EU legislation over the coming years, rather than just existing as an initiative from the agency.

Male and female hands holding tight together on black isolated background. Love, relations, support, together forever concept. Copy space, cutout, low key

The European Medicines Agency is aware that its US counterpart, the Food and Drug Administration, offers a “much higher variety” of early support mechanisms for sponsors, but it is aiming to support companies as much as it can, according to the head of the agency’s scientific advisory office, Iordanis Gravanis.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rare Diseases

More from Pink Sheet